Application
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);Application
Figure 1: Western blot analysis using CD30 mAb against human CD30 (AA: 536-590) recombinant protein. (Expected MW is 32 kDa)Application
Figure 2: Western blot analysis using CD30 mouse mAb against Hela cell lysate.Application
Figure 3: Flow cytometric analysis of Hela cells using CD30 mouse mAb (green) and negative control (red).| Product Name | CD30 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | CD30; Ki-1; D1S166E; TNFRSF8 |
| Immunogen | Purified recombinant fragment of human CD30 expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBFCMICC/IF |
| WB:1:250~1:1000 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | CD30 Ki-1 D1S166E TNFRSF8 |
|---|---|
| Molecular Weight(MW) | N/A |
| Entrez Gene | 943 |
|---|
Application
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Application
Figure 1: Western blot analysis using CD30 mAb against human CD30 (AA: 536-590) recombinant protein. (Expected MW is 32 kDa)
Application
Figure 2: Western blot analysis using CD30 mouse mAb against Hela cell lysate.
Application
Figure 3: Flow cytometric analysis of Hela cells using CD30 mouse mAb (green) and negative control (red).| Application Notes | WB:1:250~1:1000 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Ascitic fluid containing 0.03% sodium azide. |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
